Hugh Martin's stock holdings at Pacific Biosciences showed considerable changes over a few years. Initially, he held over 1.3 million shares, including significant stock options. His wealth in stocks peaked notably in January 2021, reaching around $14.52 million before gradually...

Hugh Martin's stock holdings at Pacific Biosciences showed considerable changes over a few years. Initially, he held over 1.3 million shares, including significant stock options. His wealth in stocks peaked notably in January 2021, reaching around $14.52 million before gradually declining to about $3.9 million by early 2024. His stock options allowed participation in the company’s growth but also reflected the company's volatile market performance during that time. This pattern indicated a strategic approach to his investments tied closely to the company's successes and challenges.